Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSSE Regulatory News (SSE)

Share Price Information for SSE (SSE)

Share Price is delayed by 15 minutes
Get Live Data
2,354.00    -4.00 (-0.17%)
Bid:
2,351.00
Ask:
2,352.00
Spread: 1.00 (0.043%)
Market Cap: £28.39b
SSE Live PriceLast checked at - London Stock Exchange

Intraday SSE Share Chart

Non-Discretionary Share Buyback Programme

30 Sep 2024 10:03

RNS Number : 2321G
SSE PLC
30 September 2024
 

 

SSE PLC

Non-Discretionary Share Buyback Programme

 

 

As previously announced on 29 August 2024, SSE plc (the "Company" or "SSE") has today commenced a programme to repurchase ordinary shares up to a maximum amount of £75,000,000 (the "Buyback"). The Buyback is being undertaken solely in order to honour SSE's commitment to cap scrip dividend take-up at 25% in respect of the financial year ended 31 March 2024, in line with the Company's long-standing dividend plan to 2026/27. 

 

The Company has provided irrevocable, non-discretionary instructions to UBS AG London Branch ("UBS") in relation to the Buyback, which commences today, 30 September 2024 and ends no later than 12 November 2024 (the "Programme"). UBS will act as principal for the simultaneous on-sale of such shares to the Company and will make its trading decisions concerning the timing of the purchases of the Company's ordinary shares independently of the Company.

 

The Programme will not exceed 3,806,487 ordinary shares, and the maximum pecuniary amount allocated to it is £75,000,000 (excluding expenses). The repurchased ordinary shares will be held in treasury pending their cancellation or re-issue in due course.

 

Any acquisitions under the Programme will be carried out within certain pre-set parameters, and in accordance with the Company's general authority to repurchase ordinary shares granted by shareholders at the Company's Annual General Meeting on 18 July 2024 (being up to 109,345,335 ordinary shares), Chapter 9 of the Financial Conduct Authority's UK Listing Rules, the Market Abuse Regulation (596/2014) as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 and as amended (including by the Market Abuse (Amendment) (EU Exit) Regulations 2019) ("MAR") and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the conditions applicable to buy-back programmes and stabilisation measures as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 and as amended (including by the Technical Standards (Market Abuse Regulation) (EU Exit) Instrument 2019). The Company confirms that it currently has no unpublished inside information.

 

 

 

Enquiries

 

 

Investors

SSE Investor Relations

ir@sse.com

Media

SSE Media

media@sse.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSWPUBABUPCURU
Date   Source Headline
9th Jun 20264:34 pmRNSDirector/PDMR Shareholding
9th Jun 20263:47 pmRNSNotification of Admission to Trading
5th Jun 202612:39 pmRNSDirector/PDMR Shareholding
2nd Jun 20263:44 pmRNSIssue of Hybrid Capital Securities
1st Jun 202612:30 pmRNSAdmission to Trading
1st Jun 202612:21 pmRNSTotal Voting Rights
28th May 20267:00 amRNSPreliminary Results
7th May 20262:49 pmRNSDirector/PDMR Shareholding
1st May 20268:43 amRNSTotal Voting Rights
29th Apr 20264:38 pmRNSHolding(s) in Company
22nd Apr 20268:42 amRNSHolding(s) in Company
9th Apr 20264:45 pmRNSDirector/PDMR Shareholding
7th Apr 20262:27 pmRNSDirector/PDMR Shareholding
2nd Apr 20267:01 amEQSSSE PLC: Trading Update
1st Apr 20267:01 amEQSTotal Voting Rights
20th Mar 20262:57 pmRNSAdmission of Further Securities to Trading
9th Mar 20263:06 pmRNSDirector/PDMR Shareholding
9th Mar 20263:06 pmRNSDirector/PDMR Shareholding
2nd Mar 20267:00 amEQSTotal Voting Rights
2nd Mar 20267:00 amRNSSSENT accepts Ofgem’s RIIO-T3 Final Determination
24th Feb 20267:00 amRNSNotice of Redemption
12th Feb 20264:05 pmRNSDirector/PDMR Shareholding
11th Feb 20263:15 pmRNSHolding(s) in Company
10th Feb 20264:44 pmRNSDirector/PDMR Shareholding
4th Feb 202611:46 amRNSDirector/PDMR Shareholding
4th Feb 20267:00 amRNSQ3 Trading Statement
2nd Feb 20267:00 amEQSSSE PLC: Total Voting Rights
30th Jan 20262:52 pmRNSDirector/PDMR Shareholding
29th Jan 202612:00 pmRNSDirector/PDMR Shareholding
21st Jan 20264:15 pmRNSAdditional Admission Application
14th Jan 20267:25 amRNSSSE secures 1.4GW CfD for Berwick Bank Wind Farm
8th Jan 20263:28 pmRNSScrip Alternative
8th Jan 20262:54 pmRNSDirector/PDMR Shareholding
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
30th Dec 202510:33 amRNSDirector/PDMR Shareholding
30th Dec 202510:33 amRNSDirector/PDMR Shareholding
19th Dec 20257:00 amRNSSSEN Transmission-£1bn Facility backed by the NWF
19th Dec 20257:00 amRNSSSEN Transmission-£1bn Facility backed by the NWF
11th Dec 202511:40 amRNSScrip Dividend Scheme
10th Dec 20252:35 pmRNSHolding(s) in Company
10th Dec 20252:06 pmRNS2025 Sustainability Financing Framework
9th Dec 20253:50 pmRNSHolding(s) in Company
9th Dec 20253:48 pmRNSHolding(s) in Company
9th Dec 20251:52 pmRNSHolding(s) in Company
9th Dec 20251:41 pmRNSDirector/PDMR Shareholding
8th Dec 20251:14 pmRNSDirector/PDMR Shareholding
4th Dec 202511:44 amRNSHolding(s) in Company
4th Dec 20257:01 amRNSSSENT response to RIIO-T3 Final Determination
3rd Dec 202510:10 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.